1.Hepatocarcinogenesis in liver cirrhosis: imaging diagnosis.
Journal of Korean Medical Science 1998;13(2):103-116
Hepatocellular carcinoma (HCC) frequently occurs in association with liver cirrhosis, as chronic liver disease is one of the most important factors in carcinogenesis. In addition to HCCs, recent reports of pathologic studies of resected specimens from cirrhotic liver describe associated small nodular lesions such as regenerative nodule, dysplastic nodule (adenomatous hyperplasia), and dysplastic nodule with subfocus of HCC (early HCC). In hepatocarcinogenesis of the cirrhotic liver, a regenerative nodule might be the first step in the development of HCC, going through phases of dysplastic nodule, early HCC and early advanced HCC in a multistep fashion. Fortunately, recent advances in various imaging techniques have facilitated the verification of these nodules. In this review, new nomenclature of small hepatocellular nodules, and detection and characterization of hepatic nodules in carcinogenesis with various imaging techniques are described with focus on the premalignant lesions and early stage of HCC. In addition, the efficacy of various imaging techniques for diagnosing them is discussed. Although the terms and definitions of these nodules are still variable and controversial, familiarity with the concept of these borderline lesions is important.
Carcinoma, Hepatocellular/pathology
;
Carcinoma, Hepatocellular/diagnosis*
;
Carcinoma, Hepatocellular/complications
;
Diagnostic Imaging*/methods
;
Human
;
Liver Cirrhosis/pathology
;
Liver Cirrhosis/diagnosis*
;
Liver Cirrhosis/complications
;
Patient Care Management
;
Terminology
3.Spontaneous Neoplastic Remission of Hepatocellular Carcinoma.
Sung Bae KIM ; Wonseok KANG ; Seung Hwan SHIN ; Hee Seung LEE ; Sang Hoon LEE ; Gi Hong CHOI ; Jun Yong PARK
The Korean Journal of Gastroenterology 2015;65(5):312-315
We report on a case of a 57-year-old male who underwent a curative resection for hepatocellular carcinoma (HCC) with histological confirmation of a spontaneously necrotized tumor. Initial serum AFP level was 4,778 ng/mL. A 3.7 cm hyperechoic mass in segment 6 of the liver was observed on ultrasonography and dynamic contrast-enhanced liver MRI showed a 3.7x3.1 cm sized HCC. He was scheduled to undergo curative surgical resection under the clinical diagnosis of an early stage HCC (Barcelona Clinic Liver Cancer stage A). Without treatment, the serum AFP level declined rapidly to 50 ng/mL over five weeks. He underwent curative wedge resection of segment 6 of the liver. Histology revealed complete necrosis of the mass rimmed by inflamed fibrous capsule on a background of HBV-related cirrhosis with infiltration of lymphoplasma cells. Exact pathophysiology underlying this event is unknown. Among the proposed mechanisms of spontaneous neoplastic remission of HCC, circulatory disturbance and activation of host immune response offer the most scientific explanation for the complete histologic necrosis of HCC in the resected mass seen in our patient.
Carcinoma, Hepatocellular/*diagnosis/diagnostic imaging/pathology
;
Hepatitis B/complications/diagnosis
;
Humans
;
Liver/diagnostic imaging/pathology
;
Liver Cirrhosis/etiology
;
Liver Neoplasms/*diagnosis/diagnostic imaging/pathology
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Necrosis
;
Radiography
;
Remission, Spontaneous
;
Ultrasonography
;
alpha-Fetoproteins/analysis
5.Contrast-enhanced ultrasound in the diagnosis of benign and malignant hepatic tumors.
Yingfeng JIANG ; Qichang ZHOU ; Caiyi ZHU
Journal of Central South University(Medical Sciences) 2012;37(1):53-56
OBJECTIVE:
To determine the value of contrast-enhanced ultrasound in the diagnosis of benign and malignant hepatic tumors.
METHODS:
A total of 83 patients with 123 focal liver lesions (FLLs) underwent contrast enhanced ultrasound (CEUS) examination. The contrast enhanced characterization of FLLs were compared.
RESULTS:
All the 103 lesions in hepatocallular carcinoma improved quickly in the arterial phase or portal phase. Altogether 98 lesions (95%) washed out during the late phase but the rest 5 lesions (5%) did not. Of the 69 lesions of hepatocellular carcinoma, 53(77%) enhanced global in the arterial phase or portal phase, and the rest 16 (23%) showed inhomogeneous enhancement but no enhancement in the central area during arterial phase or portal phase. A total of 66(96%) presented wash-out during the late phase, and 3(4%) had no wash-out. Of the 34 lesions of metastatic hepatic carcinoma, 24(71%)presented inhomogeneous enhancement in the arterial phase or portal phase, 10(29%) enhanced globally in the arterial phase or portal phase, 32 (94%) presented wash-out during the late phase, and 2(6%) had no wash-out in the late phase. Of the 20 lesions of benign hepatic tumor, 18(90%) presented inhomogeneous enhancement slowly in the arterial phase or portal phase, 14 (70%) slightly enhanced, and 20 (100%) presented no wash-out in the the late phase.
CONCLUSION
CEUS can improve the accuracy of diagnosis of benign and malignant hepatic tumors.
Adult
;
Aged
;
Aged, 80 and over
;
Carcinoma, Hepatocellular
;
diagnostic imaging
;
pathology
;
Contrast Media
;
Diagnosis, Differential
;
Female
;
Hemangioma
;
diagnostic imaging
;
pathology
;
Humans
;
Image Enhancement
;
Liver Neoplasms
;
diagnostic imaging
;
pathology
;
secondary
;
Male
;
Middle Aged
;
Ultrasonography
6.Diagnostic value of multislice spiral CT and MRI in detection of tumor recurrence after liver transplantation for hepatocellular carcinoma.
Jin WANG ; Bing-jun HE ; Zai-bo JIANG ; Ya-qin ZHANG ; Hong SHAN ; Ru XIAO ; Jian-sheng ZHANG ; Lin LUO ; Si-chi KUANG ; Gui-hua CHEN ; Yang YANG
Chinese Journal of Oncology 2009;31(9):691-696
OBJECTIVETo investigate the manifestation and diagnostic value of multislice spiral CT (MSCT) and MRI imaging in detection of tumor recurrence after liver transplantation for hepatocellular carcinoma (HCC).
METHODSThe clinical data of 161 consecutive HCC patients who underwent orthotopic liver transplantation were retrospectively reviewed. Twenty-nine HCC patients were classified by pTNM according to the "Pittsburgh criteria". MSCT and MRI findings of tumor recurrence after liver transplantation were evaluated retrospectively in 29 stage II-IVb HCC patients. The recurrence site and relapse interval between liver transplantation and recurrence were analyzed.
RESULTSLung tumor recurrence were found in 21 cases, presented as cotton-like lesions in a diameter of 2 - 3 cm, with a clear margin and homogeneous density. Pleural tumor recurrence was detected in 4 cases. Liver tumor recurrence were found in 9 cases, which can be divided into four subtypes: multinodular in 4 cases, diffuse lesion in 2 cases, huge mass in 2 cases, and uninodular in 1 case. Two cases showed tumor thrombus in the inferior vena cava and portal vein. Lymph node tumor recurrence was found in 9 cases, presented as multiple nodules at hepatic hilum, lesser peritoneal sac, posterior mediastinum, retroperitoneum, or around pancreatic head, and accompanied with merging and necrosis in one case. Bone tumor recurrence were found as osteolytic destruction in 4 cases, and accompanied with adjacent soft-tissue mass in 2 cases. The recurrence sites of the 29 cases were as following: lung (21 cases, 72.4%), liver (9 cases, 31.0%), lymph nodes (9 cases, 31.0%), bone (4 cases, 13.8%) and other sites (3 cases, 10.3%). Lung tumor recurrence was found in all the 10 stage IVb patients with tumor recurrence after liver transplantation, significantly more frequent than that in stage IVa patients (P = 0.023). After liver transplantation, all 25 patients with stage III approximately IVb HCC developed recurrence within one year, but in the 4 cases with stage II HCC at one year later (P = 0.009).
CONCLUSIONThe results of our study show that in hepatocellular carcinoma patients after liver transplantation, the lung and pleura are the most frequent site of recurrence, followed by liver, lymph node and bone as the second and third sites. The Stage IVb hepatocellular carcinoma should be regarded as a contradiction for liver transplantation due to rapid recurrence. Tumor recurrence occurs later in stage II HCC than in stage III approximately IVb patients. MSCT and MRI are of significant importance in diagnosis and formulating operation plan in HCC patients with recurrence after liver transplantation.
Adult ; Carcinoma, Hepatocellular ; diagnosis ; diagnostic imaging ; secondary ; surgery ; Female ; Follow-Up Studies ; Humans ; Liver Neoplasms ; diagnosis ; diagnostic imaging ; pathology ; surgery ; Liver Transplantation ; Lung Neoplasms ; diagnosis ; diagnostic imaging ; secondary ; Lymphatic Metastasis ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; diagnosis ; diagnostic imaging ; Neoplastic Cells, Circulating ; Pleural Neoplasms ; diagnosis ; diagnostic imaging ; secondary ; Retrospective Studies ; Tomography, Spiral Computed ; methods
7.A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016.
Clinical and Molecular Hepatology 2016;22(1):7-17
Many guidelines for hepatocellular carcinoma (HCC) have been published and updated globally. In contrast to other cancers, there is a range of treatment options for HCC involving several multidisciplinary care of the patient. Consequently, enormous heterogeneity in management trends has been observed. To support standard care for HCC, we systematically appraised 8 current guidelines for HCC around the world, including 3 guidelines from Asia, 2 from Europe, and 3 from the United States according to the selection criteria of credibility influence and multi-faceted. After a systematic appraisal, we found that these guidelines have both similarities and dissimilarities in terms of surveillance and treatment allocation recommendations due to regional differences in disease and other variables (diagnosis, staging systems) secondary to the lack of a solid, high level of evidence. In contrast to other tumors, the geographic differences in tumor biology (i.e., areas of increased hepatitis B prevalence) and available resources (organ availability for transplantation, medical technology, accessibility to treatment, health systems, and health resources) make it impractical to have an internationally universal guideline for all patients with HCC. Although Barcelona-Clinic Liver Cancer (BCLC) has long been dominant system for treatment-guiding staging of HCC, many Asia-pacific experts do not fully agree with its principle. The concepts of BCLC, for surgical resection or other locoregional therapy, are considered too conservative. Asian guidelines represent consensus about surgical resection and TACE indication for more advanced tumor.
Algorithms
;
Carcinoma, Hepatocellular/diagnostic imaging/pathology/*therapy
;
Chemoembolization, Therapeutic
;
Guidelines as Topic
;
Humans
;
Liver Neoplasms/diagnosis/pathology/*therapy
;
Liver Transplantation
;
Neoplasm Staging
;
alpha-Fetoproteins/analysis
8.Icteric Intraductal Hepatocellular Carcinoma and Bile Duct Thrombus Masquerading as Hilar Cholangiocarcinoma.
Ye Xin KOH ; Ser Yee LEE ; Aik Yong CHOK ; Alexander Yf CHUNG
Annals of the Academy of Medicine, Singapore 2016;45(3):113-116
Aged
;
Bile Duct Diseases
;
complications
;
diagnostic imaging
;
pathology
;
Bile Duct Neoplasms
;
diagnosis
;
Carcinoma, Hepatocellular
;
complications
;
diagnostic imaging
;
pathology
;
Diagnosis, Differential
;
Humans
;
Jaundice, Obstructive
;
etiology
;
Klatskin Tumor
;
diagnosis
;
Liver Neoplasms
;
complications
;
diagnostic imaging
;
pathology
;
Male
;
Middle Aged
;
Thrombosis
;
complications
;
diagnostic imaging
;
pathology
;
Tomography, X-Ray Computed
9.Focal lesions in cirrhotic liver: comparing MR imaging during arterial portography with Gd-enhanced dynamic MR imaging.
Jeong Sik YU ; Ki Whang KIM ; Jong Tae LEE ; Hyung Sik YOO
Yonsei Medical Journal 2000;41(5):546-555
The purpose of this study was to document the additional value of MR imaging during arterial portography (MRAP) in patients examined with intravenous contrast-enhanced dynamic MR imaging for the assessment of focal lesions in patients with cirrhosis or chronic viral hepatitis. The MR images of 24 patients with 39 hepatocellular carcinomas and 18 benign hepatocellular nodules examined with dynamic MR imaging and MRAP within a 14-day interval were retrospectively reviewed. For 39 hepatocellular carcinomas, MRAP revealed 37 perfusion defects (95%), while dynamic MR imaging demonstrated 35 occurrences of nodular contrast-enhancement (90%) on arterial dominant phases. Among the 11 benign nodules misinterpreted as hepatocellular carcinoma due to their high signal intensities on arterial-dominant phases of dynamic MR imaging, eight (73%) showed intratumoral portal venous perfusion on MRAP and were regarded as benign nodules. As a result of its high sensitivity and its potential ability to enable differentiation of benign and malignant hepatocellular nodules, MRAP can be added to dynamic MR imaging for planning future management in patients with equivocal hepatocellular nodules in the cirrhotic liver.
Adult
;
Carcinoma, Hepatocellular/diagnosis
;
Comparative Study
;
Female
;
Gadolinium/diagnostic use
;
Hepatic Artery/radiography
;
Human
;
Liver/pathology*
;
Liver Cirrhosis/diagnosis*
;
Liver Neoplasms/diagnosis
;
Magnetic Resonance Imaging/methods*
;
Male
;
Middle Age
;
Portography
10.Focal nodular hyperplasia of liver: a clinicopathologic study of 238 patients.
Ling-li CHEN ; Yuan JI ; Jian-fang XU ; Shao-hua LU ; Ying-yong HOU ; Jun HOU ; Akesu SUJIE ; Hai-ying ZENG ; Yun-shan TAN
Chinese Journal of Pathology 2011;40(1):17-22
OBJECTIVETo study the clinicopathologic features of focal nodular hyperplasia (FNH) of liver.
METHODSThe clinical, radiologic, pathologic findings and follow-up data of 238 cases of FNH were retrospectively analyzed.
RESULTSThe patients included 93 females and 145 males. The age of the patients ranged from 11 to 77 years (median = 39.1 years). Amongst the 233 patients who had clinical information available, 188 were asymptomatic, 216 had no history of hepatitis B and/or C infection and 232 had negative serum alpha-fetoprotein level. Amongst the 185 patients who had undergone radiologic examination, 123 (66.5%) were accurately diagnosed as such. Macroscopically, of the 284 lesions from 238 patients, the average diameter was 3.7 cm. Two hundred and fifteen cases (90.3%) were solitary, 172 cases were located in the right lobe and 115(40.5%) had central stellate fibrotic scars or lobulated cut surface. Histologically, 229 lesions belonged to classic type and 9 lesions were of non-classic type. The latter was further classified as the telangiectatic form (6 lesions) and the mixed hyperplastic and adenomatous form (3 lesions). There was no evidence of significant cytologic atypia. Follow-up data were available in 173 patients (72.7%). None of them died of the disease and 2 patients suffered from relapses after 2 and 4 years, respectively.
CONCLUSIONSFNH is a hyperplastic response of normal liver cells to local blood flow anomalies. It has no obvious sex predilection and more than 66% can be diagnosed accurately with radiologic examination. The lesions in the current study show no cytologic atypia.
Adenoma, Liver Cell ; pathology ; Adolescent ; Adult ; Aged ; Biopsy ; Carcinoma, Hepatocellular ; pathology ; Child ; Diagnosis, Differential ; Female ; Focal Nodular Hyperplasia ; diagnosis ; diagnostic imaging ; pathology ; surgery ; Follow-Up Studies ; Humans ; Liver ; pathology ; Liver Neoplasms ; pathology ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Recurrence ; Retrospective Studies ; Tomography, X-Ray Computed ; Ultrasonography ; Young Adult